Vaxneuvance

$50,000.00

Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine or PCV15) is a prescription vaccine made by Merck. It protects people 6 weeks of age and older against invasive pneumococcal diseases, like meningitis and blood infections, caused by 15 specific types of Streptococcus pneumoniae bacteria

Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine or PCV15) is a prescription vaccine made by Merck. It protects people 6 weeks of age and older against invasive pneumococcal diseases, like meningitis and blood infections, caused by 15 specific types of Streptococcus pneumoniae bacteria